Research Papers
This database includes peer-reviewed publications authored or funded by TB Alliance. Use the tags on the right to filter by subject, or search for a particular author or term using the search bar.
Displaying 178 papers
Pretomanid with Bedaquiline and Linezolid for Drug Resistant TB: A Comparison of Prospective Cohorts
4/2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
3/2021 - International Journal of Tuberculosis and Lung Disease
No antimicrobial resistance research agenda without tuberculosis
8/2020 - The Lancet Global Health
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
3/2020 - The New England Journal of Medicine
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
1/2020 - Antimicrobial Agents and Chemotherapy
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
11/2019 - The Lancet Respiratory Medicine
Daily Dosing for Bedaquiline in Patients with Tuberculosis
10/2019 - Antimicrobial Agents and Chemotheraphy
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations
9/2019 - BMC Infectious Diseases
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
8/2019 - BMC Pulmonary Medicine
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
8/2019 - Antimicrobial Agents and Chemotheraphy
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
7/2019 - Antimicrobial Agents and Chemotheraphy
Antibacterial Activity of Coastal Plants and Marine Sponges from Kei Island Indonesia against Bacterial Fish Pathogens
7/2019 - Pharmacognosy Journal
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
4/2019 - Antimicrobial Agents and Chemotheraphy